Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.73 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.63 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.63 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.62 |
| ▸ | CA2 | P00918 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octisalate SCHEMBL29428934 | 1.00 | LMNA (0.73) | LMNAPRSS1PRSS2PRSS3ALDH1A1 | |
| SCHEMBL5670019 | 0.93 | LMNA (0.65) | LMNAPRSS1PRSS2PRSS3ALDH1A1 | |
| SCHEMBL29500373 | 0.93 | LMNA (0.65) | LMNAPRSS1PRSS2PRSS3ALDH1A1 | |
| SCHEMBL4167259 | 0.89 | PRSS1 (0.74) | LMNAPRSS1PRSS2PRSS3ALDH1A1 | |
| Octisalate SCHEMBL6023812 | 0.88 | LMNA (0.86) | LMNAPRSS1PRSS2PRSS3ALDH1A1 | |
| Octisalate SCHEMBL6853192 | 0.88 | LMNA (0.90) | LMNAPRSS1PRSS2PRSS3ALDH1A1 | |
| Octisalate SCHEMBL20395019 | 0.88 | LMNA (0.90) | LMNAPRSS1PRSS2PRSS3ALDH1A1 | |
| Octisalate SCHEMBL29637131 | 0.86 | LMNA (0.68) | LMNAPRSS1PRSS2PRSS3ALDH1A1 | |
| SCHEMBL29922922 | 0.86 | ALDH1A1 (0.63) | LMNAALDH1A1CYP3A4TSHRMAPK1 | |
| SCHEMBL29390937 | 0.86 | ALDH1A1 (0.63) | LMNAALDH1A1CYP3A4TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110130704-A1 | COMBINATION OF A LIGHT RAY AND A LIPASE-BIOCONVERTIBLE COMPOUND FOR IMPROVING SKIN AND/OR HAIR APPEARANCE | L'OREAL (FR) | 2011-06-02 | — | — | US | disclosed |
| US-20060104940-A1 | Cosmetic, pharmaceutical and dermatological preparations comprising copolymer waxes | CLARIANT GMBH | 2006-05-18 | — | — | US | disclosed |
| EP-1324821-A2 | EMULSION COMPRISING A BLEND OF CATIONIC, ANIONIC AND BRIDGING SURFACTANS, OIL AND WATER | STEPAN COMPANY (US) | 2003-07-09 | — | — | EP | disclosed |
| EP-1318720-A2 | ANTIMICROBIAL TERNARY SURFACTANT BLEND COMPRISING CATIONIC, ANIONIC, AND BRIDGING SURFACTANTS, AND METHODS OF PREPARING SAME | STEPAN COMPANY (US) | 2003-06-18 | — | — | EP | disclosed |
| WO-2002022083-A2 | EMULSION COMPRISING A BLEND OF CATIONIC, ANIONIC AND BRIDGING SURFACTANTS, OIL AND WATER | STEPAN COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |
| WO-2002021916-A2 | ANTIMICROBIAL TERNARY SURFACTANT BLEND COMPRISING CATIONIC, ANIONIC, AND BRIDGING SURFACTANTS, AND METHODS OF PREPARING SAME | STEPAN COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |
| EP-0814760-A1 | SUBSTITUTED o-AMINOCARBONYLBENZOIC ACID SALTS AND THEIR USE AS SUNSCREENS | STEPAN COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| WO-1997025971-A1 | SUBSTITUTED o-AMINOCARBONYLBENZOIC ACID SALTS AND THEIR USE AS SUNSCREENS | STEPAN COMPANY (US) | 1997-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060104940-A1 | Cosmetic, pharmaceutical and dermatological preparations comprising copolymer waxes | CUTA, ACMSD, DEGS1 | LMNA 3707/4885PRSS1 2629/4885PRSS2 3397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.